Caris Life Sciences, Inc. (CAI)
NASDAQ: CAI · Real-Time Price · USD
33.31
-0.35 (-1.04%)
Sep 17, 2025, 3:33 PM EDT - Market open

Caris Life Sciences Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022
Period Ending
Sep '25 Dec '24 Dec '23 Dec '22
9,368---
Enterprise Value
9,043---
Debt / Equity Ratio
0.93-1.53-11.041.08
Asset Turnover
-1.090.54-
Inventory Turnover
-5.244.48-
Quick Ratio
8.560.931.863.29
Current Ratio
9.241.302.553.77
Return on Equity (ROE)
---293.82%-
Return on Assets (ROA)
--42.48%-35.34%-
Return on Capital (ROIC)
--93.29%-55.45%-
Buyback Yield / Dilution
-28.88%-1.59%-4.73%-
Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q